Jiang J, Sharma SD, Nakamura S, Lai JY, Fink JL, Hruby VJ
Step three: ask whether your thyroid is optimally controlled and whether starting semaglutide injection is safe now or requires a waiting period
van der Maaden K, Sekerdag E, Jiskoot W, Bouwstra J
Retatrutide tends to show steeper initial weight loss curves given its broader metabolic effects, while cagrilintide shows a more gradual, steady decline
The emergence of oral formulations and combination therapies may also enhance patient adherence and expand treatment options, highlighting the need for continued research to optimize the use of GLP-1 receptor agonists and co-agonists across diverse populations, they say
Ozempic is one of several FDA-approved options for adults with T2D who need better glycemic control, especially when there is also overweight, obesity, or established cardiovascular disease